In 2024, Qiagen's return on assets (ROA) was 0.06, a -17.08% increase from the 0.07 ROA in the previous year.

Qiagen Aktienanalyse

What does Qiagen do?

Qiagen NV is a biotechnology company based in Venlo, Netherlands. The company was founded in 1984 as a spin-off from the University of Düsseldorf and has since become a leading provider of molecular diagnostic products and systems. Qiagen operates in four business areas: Life Sciences, Molecular Diagnostics, Applied Testing, and Pharma. Life Sciences is the largest business area of the company and offers a wide range of products for DNA sequencing, gene expression, RNA isolation and analysis, as well as protein analysis. Molecular Diagnostics specializes in diagnostic tests for diseases such as cancer, infections, and genetic disorders. Applied Testing provides solutions for forensic analysis and food and environmental analysis, while Pharma offers products and services for drug discovery and development. In recent years, Qiagen has focused mainly on the development of molecular diagnostic tests for cancer and infection-related diseases such as HIV, hepatitis, and tuberculosis. These tests enable earlier detection of diseases and more targeted therapy, improving patient care and reducing healthcare costs. One example of a successful Qiagen product is the Cobas HPV Test, a molecular diagnostic test for the detection of human papillomaviruses (HPV) responsible for cervical cancer. The test is distributed by Roche Diagnostics and is one of the best-selling molecular diagnostic tests in the world. Qiagen also has a strong presence in academic research and is a major provider of tools and technologies for DNA sequencing and genome research. Customers include leading research institutes, universities, and pharmaceutical companies. In recent years, Qiagen has also expanded through acquisitions to expand its offering of products and technologies and enter new markets. For example, in 2018, the company acquired N-of-One, a provider of artificial intelligence in cancer diagnostics, and NeuMoDx Molecular, a provider of molecular diagnostic platforms for laboratories. In 2020, Qiagen also played a crucial role in the development of tests for the new coronavirus (SARS-CoV-2). The company, together with other leading diagnostic companies, developed molecular diagnostic tests for rapid and reliable diagnosis of COVID-19. Overall, Qiagen is an important player in the biotech industry, offering a wide range of products and services for molecular diagnostics, genome research, and pharmaceutical research. Qiagen has a strong competitive position due to its innovative products and technologies, strong presence in academic research, and strategic acquisitions to expand its product portfolio and market access. Qiagen ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding Qiagen's Return on Assets (ROA)

Qiagen's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Qiagen's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Qiagen's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Qiagen’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Qiagen stock

What is the Return on Assets (ROA) of Qiagen this year?

The Return on Assets (ROA) of Qiagen is 0.06 undefined this year.

What was the ROA of Qiagen compared to the previous year?

The ROA of Qiagen has increased by -17.08% compared to the previous year.

What consequences do high ROA have for investors of Qiagen?

A high ROA is advantageous for investors of Qiagen, as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in Qiagen?

A low ROA can be unfavorable for investors of Qiagen as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of Qiagen affect the company?

An increase in ROA of Qiagen can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of Qiagen impact the company?

A reduction in the ROA of Qiagen can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of Qiagen?

Some factors that can influence the ROA of Qiagen include revenue, operating costs, asset structure, and industry average.

Why is the ROA of Qiagen important for investors?

The ROA of Qiagen is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can Qiagen take to improve ROA?

To improve ROA, Qiagen can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does Qiagen pay?

Over the past 12 months, Qiagen paid a dividend of 1.08 USD . This corresponds to a dividend yield of about 2.43 %. For the coming 12 months, Qiagen is expected to pay a dividend of 0 USD.

What is the dividend yield of Qiagen?

The current dividend yield of Qiagen is 2.43 %.

When does Qiagen pay dividends?

Qiagen pays a quarterly dividend. This is distributed in the months of February, February, February, February.

How secure is the dividend of Qiagen?

Qiagen paid dividends every year for the past 5 years.

What is the dividend of Qiagen?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Qiagen located?

Qiagen is assigned to the 'Health' sector.

Wann musste ich die Aktien von Qiagen kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Qiagen from 2/1/2024 amounting to 1.32 USD, you needed to have the stock in your portfolio before the ex-date on 1/30/2024.

When did Qiagen pay the last dividend?

The last dividend was paid out on 2/1/2024.

What was the dividend of Qiagen in the year 2023?

In the year 2023, Qiagen distributed 0 USD as dividends.

In which currency does Qiagen pay out the dividend?

The dividends of Qiagen are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Qiagen stock can be added to a savings plan with the following providers: Trade Republic, Scalable Capital and Consorsbank

Andere Kennzahlen von Qiagen

Our stock analysis for Qiagen Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Qiagen Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.